184 related articles for article (PubMed ID: 31970572)
1. Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.
Si Y; Yuan P; Hu N; Wang X; Ju J; Wang J; Ma F; Luo Y; Zhang P; Li Q; Xu B
Ann Surg Oncol; 2020 Apr; 27(4):1025-1033. PubMed ID: 31970572
[TBL] [Abstract][Full Text] [Related]
2. Could local surgery improve survival in de novo stage IV breast cancer?
Xiong Z; Deng G; Wang J; Li X; Xie X; Shuang Z; Wang X
BMC Cancer; 2018 Sep; 18(1):885. PubMed ID: 30200932
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
[TBL] [Abstract][Full Text] [Related]
4. Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
Wang K; Shi Y; Li ZY; Xiao YL; Li J; Zhang X; Li HY
Eur J Surg Oncol; 2019 Aug; 45(8):1364-1372. PubMed ID: 30837102
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
[TBL] [Abstract][Full Text] [Related]
6. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
[TBL] [Abstract][Full Text] [Related]
7. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
[TBL] [Abstract][Full Text] [Related]
8. [Local recurrence based on size after conservative surgery in breast cancer stage T1-T2. A population-based study].
Martínez-Ramos D; Fortea-Sanchis C; Escrig-Sos J; Prats-de Puig M; Queralt-Martín R; Salvador-Sanchis JL
Cir Cir; 2014; 82(3):252-61. PubMed ID: 25238466
[TBL] [Abstract][Full Text] [Related]
9. Survival differences among women with de novo stage IV and relapsed breast cancer.
Dawood S; Broglio K; Ensor J; Hortobagyi GN; Giordano SH
Ann Oncol; 2010 Nov; 21(11):2169-2174. PubMed ID: 20427349
[TBL] [Abstract][Full Text] [Related]
10. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.
Lang JE; Tereffe W; Mitchell MP; Rao R; Feng L; Meric-Bernstam F; Bedrosian I; Kuerer HM; Hunt KK; Hortobagyi GN; Babiera GV
Ann Surg Oncol; 2013 Jun; 20(6):1893-9. PubMed ID: 23306905
[TBL] [Abstract][Full Text] [Related]
11. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.
King TA; Lyman JP; Gonen M; Voci A; De Brot M; Boafo C; Sing AP; Hwang ES; Alvarado MD; Liu MC; Boughey JC; McGuire KP; Van Poznak CH; Jacobs LK; Meszoely IM; Krontiras H; Babiera GV; Norton L; Morrow M; Hudis CA
J Clin Oncol; 2016 Jul; 34(20):2359-65. PubMed ID: 27001590
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of breast conserving surgery for stages I and II breast cancer: experiences at Osaka Medical Center for Cancer and Cardiovascular Diseases.
Komoike Y; Motomura K; Inaji H; Kasugai T; Nose T; Koizumi M; Koyama H
Breast Cancer; 2002; 9(3):248-53. PubMed ID: 12185337
[TBL] [Abstract][Full Text] [Related]
14. Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China: A retrospective analysis.
Xie Y; Lv X; Luo C; Hu K; Gou Q; Xie K; Zheng H
Medicine (Baltimore); 2017 Jun; 96(22):e7048. PubMed ID: 28562563
[TBL] [Abstract][Full Text] [Related]
15. Impact of Locoregional Treatment on Prognosis of de novo Stage IV Breast Cancer: A Retrospective Long-Term Study of Chinese Population.
Wang W; Liu J; Wang J; Gao J; Wang X; Wang X
Gynecol Obstet Invest; 2019; 84(3):248-258. PubMed ID: 30448829
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcomes between women with de novo stage IV and relapsed breast cancer.
Kitagawa D; Horiguchi S; Yamashita T; Kuroi K; Shimizu K
J Nippon Med Sch; 2014; 81(3):139-47. PubMed ID: 24998960
[TBL] [Abstract][Full Text] [Related]
17. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
18. De-novo metastatic breast cancers with or without primary tumor resection - A 10-year study.
Co M; Ng J; Kwong A
Cancer Treat Res Commun; 2019; 19():100118. PubMed ID: 30825858
[TBL] [Abstract][Full Text] [Related]
19. Metastatic breast cancer: Who benefits from surgery?
Marks CE; Thomas SM; Fayanju OM; DiLalla G; Sammons S; Hwang ES; Plichta JK
Am J Surg; 2022 Jan; 223(1):81-93. PubMed ID: 34325907
[TBL] [Abstract][Full Text] [Related]
20. Is conservative surgery a good option for patients with "triple negative" breast cancer?
Martinez-Ramos D; Escrig-Sos J; Torrella-Ramos A; Alcalde-Sanchez M; Salvador-Sanchis JL
Breast; 2012 Jun; 21(3):401-5. PubMed ID: 22579462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]